Maybe, but there are a bunch of weak hands around. Don't get me wrong, Medolife is a good company but it seems CEO was ahead of himself. This is a long term one. I am surprised the merge went this fast. I aim, by the end of this year, this stock, will be fine with the FDA. Not sure what this CEO will do to cover this up any longer, the celebrity thing can't last that long, many people can be fooled but not for long.
News 
Market Data 
Discover 
